| __timestamp | Sarepta Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 94103000 | 60987000 |
| Thursday, January 1, 2015 | 146194000 | 125542000 |
| Friday, January 1, 2016 | 130000 | 210460000 |
| Sunday, January 1, 2017 | 7353000 | 275119000 |
| Monday, January 1, 2018 | 34193000 | 409539000 |
| Tuesday, January 1, 2019 | 56586000 | 547758000 |
| Wednesday, January 1, 2020 | 63382000 | 736300000 |
| Friday, January 1, 2021 | 97049000 | 904200000 |
| Saturday, January 1, 2022 | 139989000 | 1080300000 |
| Sunday, January 1, 2023 | 150343000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
Unlocking the unknown
In the competitive world of biotechnology, cost management is crucial for success. Vertex Pharmaceuticals Incorporated and Sarepta Therapeutics, Inc. have been at the forefront of this industry, each with unique strategies. Over the past decade, Vertex has consistently outpaced Sarepta in terms of cost of revenue, with a staggering 1,262% increase from 2014 to 2023. In contrast, Sarepta's cost of revenue grew by approximately 60% during the same period.
Vertex's ability to scale its operations efficiently is evident in its cost management, which has allowed it to invest heavily in research and development. This strategic focus has positioned Vertex as a leader in the biotech sector.
While Sarepta's growth has been more modest, its focus on niche markets and innovative therapies has kept it competitive. The company's cost of revenue reflects its strategic investments in groundbreaking treatments.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for GSK plc and Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Viatris Inc. vs Sarepta Therapeutics, Inc.
Insmed Incorporated vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Sarepta Therapeutics, Inc. vs Exelixis, Inc.
Cost of Revenue Trends: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and ADMA Biologics, Inc.'s Expenses
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs HUTCHMED (China) Limited